symbol,statement_type,period_end,line_item,value
VALIANTLAB.NS,income,2025-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Tax Rate For Calcs,0.3
VALIANTLAB.NS,income,2025-03-31 00:00:00,Normalized EBITDA,7553000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Total Unusual Items,0.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,-22012000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Reconciled Depreciation,20926000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Reconciled Cost Of Revenue,1165998000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,EBITDA,7553000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,EBIT,-13373000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Net Interest Income,-1753000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Interest Expense,1753000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Interest Income,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Normalized Income,-22012000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,-22012000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Total Expenses,1401540000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Rent Expense Supplemental,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Diluted Average Shares,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Basic Average Shares,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Diluted EPS,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Basic EPS,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Diluted NI Availto Com Stockholders,-22012000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Net Income Common Stockholders,-22012000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Net Income,-22012000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Minority Interests,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Net Income Including Noncontrolling Interests,-22012000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Net Income Continuous Operations,-22012000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Tax Provision,6886000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Pretax Income,-15126000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Other Non Operating Income Expenses,54348000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Special Income Charges,0.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Other Special Charges,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Write Off,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Net Non Operating Interest Income Expense,-1753000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Interest Expense Non Operating,1753000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Interest Income Non Operating,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Operating Income,-67720000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Operating Expense,235542000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Other Operating Expenses,170735000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Depreciation And Amortization In Income Statement,20926000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Depreciation Income Statement,20926000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Selling General And Administration,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Selling And Marketing Expense,
VALIANTLAB.NS,income,2025-03-31 00:00:00,General And Administrative Expense,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Rent And Landing Fees,
VALIANTLAB.NS,income,2025-03-31 00:00:00,Gross Profit,167822000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Cost Of Revenue,1165998000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Total Revenue,1333820000.0
VALIANTLAB.NS,income,2025-03-31 00:00:00,Operating Revenue,1333820000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Tax Rate For Calcs,0.3
VALIANTLAB.NS,income,2024-03-31 00:00:00,Normalized EBITDA,12739000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Total Unusual Items,0.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,3196000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Reconciled Depreciation,19656000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Reconciled Cost Of Revenue,1682521000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,EBITDA,12739000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,EBIT,-6917000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Net Interest Income,-778000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Interest Expense,778000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Interest Income,
VALIANTLAB.NS,income,2024-03-31 00:00:00,Normalized Income,3196000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,3196000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Total Expenses,1924282000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Rent Expense Supplemental,
VALIANTLAB.NS,income,2024-03-31 00:00:00,Diluted Average Shares,43450000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Basic Average Shares,43450000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Diluted EPS,0.13
VALIANTLAB.NS,income,2024-03-31 00:00:00,Basic EPS,0.13
VALIANTLAB.NS,income,2024-03-31 00:00:00,Diluted NI Availto Com Stockholders,3196000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Net Income Common Stockholders,3196000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Net Income,3196000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Minority Interests,
VALIANTLAB.NS,income,2024-03-31 00:00:00,Net Income Including Noncontrolling Interests,3196000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Net Income Continuous Operations,3196000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Tax Provision,-10891000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Pretax Income,-7695000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Other Non Operating Income Expenses,96815000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Special Income Charges,0.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Other Special Charges,
VALIANTLAB.NS,income,2024-03-31 00:00:00,Write Off,
VALIANTLAB.NS,income,2024-03-31 00:00:00,Net Non Operating Interest Income Expense,-778000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Interest Expense Non Operating,778000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Interest Income Non Operating,
VALIANTLAB.NS,income,2024-03-31 00:00:00,Operating Income,-103710000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Operating Expense,241761000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Other Operating Expenses,178978000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Depreciation And Amortization In Income Statement,19656000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Depreciation Income Statement,19656000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Selling General And Administration,
VALIANTLAB.NS,income,2024-03-31 00:00:00,Selling And Marketing Expense,
VALIANTLAB.NS,income,2024-03-31 00:00:00,General And Administrative Expense,
VALIANTLAB.NS,income,2024-03-31 00:00:00,Rent And Landing Fees,
VALIANTLAB.NS,income,2024-03-31 00:00:00,Gross Profit,138051000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Cost Of Revenue,1682521000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Total Revenue,1820572000.0
VALIANTLAB.NS,income,2024-03-31 00:00:00,Operating Revenue,1820572000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Tax Effect Of Unusual Items,0.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Tax Rate For Calcs,0.239616
VALIANTLAB.NS,income,2023-03-31 00:00:00,Normalized EBITDA,399532000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Total Unusual Items,0.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Total Unusual Items Excluding Goodwill,0.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,289983000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Reconciled Depreciation,15631000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Reconciled Cost Of Revenue,2773192000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,EBITDA,399532000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,EBIT,383901000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Net Interest Income,-2537000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Interest Expense,2537000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Interest Income,970000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Normalized Income,289983000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,289983000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Total Expenses,3003820000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Rent Expense Supplemental,210000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Diluted Average Shares,43450000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Basic Average Shares,43450000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Diluted EPS,6.673947
VALIANTLAB.NS,income,2023-03-31 00:00:00,Basic EPS,6.673947
VALIANTLAB.NS,income,2023-03-31 00:00:00,Diluted NI Availto Com Stockholders,289983000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Net Income Common Stockholders,289983000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Net Income,289983000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Minority Interests,0.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Net Income Including Noncontrolling Interests,289983000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Net Income Continuous Operations,289983000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Tax Provision,91381000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Pretax Income,381364000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Other Non Operating Income Expenses,48626000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Special Income Charges,0.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Other Special Charges,
VALIANTLAB.NS,income,2023-03-31 00:00:00,Write Off,2200000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Net Non Operating Interest Income Expense,-2537000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Interest Expense Non Operating,2537000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Interest Income Non Operating,970000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Operating Income,335275000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Operating Expense,230628000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Other Operating Expenses,168872000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Depreciation And Amortization In Income Statement,15631000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Depreciation Income Statement,15631000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Selling General And Administration,24460000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Selling And Marketing Expense,17930000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,General And Administrative Expense,6530000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Rent And Landing Fees,210000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Gross Profit,565903000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Cost Of Revenue,2773192000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Total Revenue,3339095000.0
VALIANTLAB.NS,income,2023-03-31 00:00:00,Operating Revenue,3339095000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Tax Effect Of Unusual Items,-330466.142336
VALIANTLAB.NS,income,2022-03-31 00:00:00,Tax Rate For Calcs,0.340687
VALIANTLAB.NS,income,2022-03-31 00:00:00,Normalized EBITDA,443640000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Total Unusual Items,-970000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Total Unusual Items Excluding Goodwill,-970000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,274960000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Reconciled Depreciation,24900000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Reconciled Cost Of Revenue,2392020000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,EBITDA,442670000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,EBIT,417770000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Net Interest Income,4720000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Interest Expense,730000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Interest Income,5450000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Normalized Income,275599533.857664
VALIANTLAB.NS,income,2022-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,274960000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Total Expenses,2515180000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Rent Expense Supplemental,0.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Diluted Average Shares,43450000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Basic Average Shares,43450000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Diluted EPS,6.328193
VALIANTLAB.NS,income,2022-03-31 00:00:00,Basic EPS,6.328193
VALIANTLAB.NS,income,2022-03-31 00:00:00,Diluted NI Availto Com Stockholders,274960000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Net Income Common Stockholders,274960000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Otherunder Preferred Stock Dividend,0.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Net Income,274960000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Minority Interests,
VALIANTLAB.NS,income,2022-03-31 00:00:00,Net Income Including Noncontrolling Interests,274960000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Net Income Continuous Operations,274960000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Tax Provision,142080000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Pretax Income,417040000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Other Non Operating Income Expenses,4620000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Special Income Charges,-1270000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Other Special Charges,-400000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Write Off,1670000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Net Non Operating Interest Income Expense,4720000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Interest Expense Non Operating,730000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Interest Income Non Operating,5450000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Operating Income,400050000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Operating Expense,123160000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Other Operating Expenses,35000000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Depreciation And Amortization In Income Statement,24900000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Depreciation Income Statement,24900000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Selling General And Administration,17450000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Selling And Marketing Expense,12680000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,General And Administrative Expense,4770000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Rent And Landing Fees,0.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Gross Profit,523210000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Cost Of Revenue,2392020000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Total Revenue,2915230000.0
VALIANTLAB.NS,income,2022-03-31 00:00:00,Operating Revenue,2915230000.0
VALIANTLAB.NS,income,2021-03-31 00:00:00,Tax Effect Of Unusual Items,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Tax Rate For Calcs,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Normalized EBITDA,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Total Unusual Items,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Total Unusual Items Excluding Goodwill,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Net Income From Continuing Operation Net Minority Interest,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Reconciled Depreciation,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Reconciled Cost Of Revenue,
VALIANTLAB.NS,income,2021-03-31 00:00:00,EBITDA,
VALIANTLAB.NS,income,2021-03-31 00:00:00,EBIT,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Net Interest Income,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Interest Expense,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Interest Income,3695071.0
VALIANTLAB.NS,income,2021-03-31 00:00:00,Normalized Income,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Net Income From Continuing And Discontinued Operation,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Total Expenses,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Rent Expense Supplemental,0.0
VALIANTLAB.NS,income,2021-03-31 00:00:00,Diluted Average Shares,43450000.0
VALIANTLAB.NS,income,2021-03-31 00:00:00,Basic Average Shares,43450000.0
VALIANTLAB.NS,income,2021-03-31 00:00:00,Diluted EPS,7.040967
VALIANTLAB.NS,income,2021-03-31 00:00:00,Basic EPS,7.040967
VALIANTLAB.NS,income,2021-03-31 00:00:00,Diluted NI Availto Com Stockholders,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Net Income Common Stockholders,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Otherunder Preferred Stock Dividend,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Net Income,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Minority Interests,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Net Income Including Noncontrolling Interests,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Net Income Continuous Operations,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Tax Provision,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Pretax Income,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Other Non Operating Income Expenses,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Special Income Charges,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Other Special Charges,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Write Off,0.0
VALIANTLAB.NS,income,2021-03-31 00:00:00,Net Non Operating Interest Income Expense,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Interest Expense Non Operating,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Interest Income Non Operating,3695071.0
VALIANTLAB.NS,income,2021-03-31 00:00:00,Operating Income,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Operating Expense,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Other Operating Expenses,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Depreciation And Amortization In Income Statement,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Depreciation Income Statement,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Selling General And Administration,11840000.0
VALIANTLAB.NS,income,2021-03-31 00:00:00,Selling And Marketing Expense,6290000.0
VALIANTLAB.NS,income,2021-03-31 00:00:00,General And Administrative Expense,5550000.0
VALIANTLAB.NS,income,2021-03-31 00:00:00,Rent And Landing Fees,0.0
VALIANTLAB.NS,income,2021-03-31 00:00:00,Gross Profit,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Cost Of Revenue,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Total Revenue,
VALIANTLAB.NS,income,2021-03-31 00:00:00,Operating Revenue,
